Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c)  Valdecantos, M.P. et al., 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/220136

The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ cross-talk

Títol de la revista

ISSN de la revista

Títol del volum

Resum

Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here we show how G49, an oxyntomodulin (OXM) analog and dual glucagon/glucagon-like peptide-1 receptor (GCGR/GLP-1R) agonist, triggers an inter-organ crosstalk between adipose tissue, pancreas, and liver which is initiated by a rapid release of free fatty acids (FFAs) by white adipose tissue (WAT) in a GCGR-dependent manner. This interactome leads to elevations in adiponectin and fibroblast growth factor 21 (FGF21), causing WAT beiging, brown adipose tissue (BAT) activation, increased energy expenditure (EE) and weight loss. Elevation of OXM, under basal and postprandial conditions, and similar metabolic adaptations after G49 treatment were found in plasma from patients with obesity early after metabolic bariatric surgery. These results identify G49 as a potential pharmacological alternative sharing with bariatric surgery hormonal and metabolic pathways.

Descripció

Citació

Citació

VALDECANTOS, M. pilar, RUIZ, Laura, FOLGUEIRA, Cintia, RADA, Patricia, GÓMEZ-SANTOS, Beatriz, SOLAS, Maite, HITOS, Ana b., FIELD, Joss, FRANCISCO, Vera, ESCALONA-GARRIDO, Carmen, ZAGMUTT CAROXA, Sebastián, CALDERÓN DOMÍNGUEZ, María, MERA NANÍN, Paula, GARCÍA MARTÍNEZ, Irma, MAYMÓ MASIP, Elsa, GRAJALES, Diana, ALEN, Rosa, MORA, Alfonso, SAINZ, Neira, VIDES-URRESTARAZU, Irene, VILARRASA, Nuria, ARBONES-MAINAR, Jose m., ZARAGOZA, Carlos, MORENO-ALIAGA, María j., ASPICHUETA, Patricia, FERNÁNDEZ VELEDO, Sonia, VENDRELL, Joan, SERRA I CUCURULL, Dolors, HERRERO RODRÍGUEZ, Laura, SCHREIBER, Renate, ZECHNER, Rudolf, SABIO, Guadalupe, HORNIGOLD, David, RONDINONE, Cristina m., JERMUTUS, Lutz, GRIMSBY, Joseph, VALVERDE, Ángela m.. The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ cross-talk. _Nature Communications_. 2024. Vol. 15, núm. 10342. [consulta: 24 de novembre de 2025]. ISSN: 2041-1723. [Disponible a: https://hdl.handle.net/2445/220136]

Exportar metadades

JSON - METS

Compartir registre